Hosted on MSN25d
FDA Accepts Bayer's Application for Label Expansion of NubeqaNubeqa is one of Bayer's top drugs and a potential label expansion should further boost sales. The drug generated sales of more than €1 billion in the first nine months of 2024.
Facing thousands of lawsuits and seeking protection from lawmakers, Bayer is using ads, lobbying and third-party mouthpieces ...
With Missouri Republicans split over a bill protecting Roundup-maker Bayer from lawsuits, lawmakers targeted by a mail campaign are digging in.
16d
Audacy on MSNBayer could soon avoid future cancer-related lawsuits over Roundup weed killer in MissouriThe Missouri Legislature is halfway to the finish line in helping chemical company Bayer avoid future cancer-related lawsuits over its Roundup weed killer.
But Bayer officials highlight that the U.S. Environmental Protection Agency in 2020 in a regulatory review stated "there are no risks of concern to human health when glyphosate is used in accordance ...
The nine Republican members of the Missouri Senate carry enough firepower to stage a prolonged legislative filibuster to stop ...
Bayer officials argue passing the bill would ... to human health when glyphosate is used in accordance with its current label" and it is unlikely to be a human carcinogen. Bayer has faced ...
DES MOINES, Iowa (AP) — A renewed and expanded effort from chemical giant Bayer to shield itself from ... product causes cancer if the product label otherwise complies with the U.S ...
Berlin: Bayer has announced that the first patient has been enrolled in the global Phase II panSOHO study, an open-label ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results